|
|
Clinical effect of carboprost methylate suppository combined with Bakri uterine tamponade balloon catheter in postpartum hemorrhage |
LUO Qing1,HE Limei2,FENG Qian2,BAI Chunxiao2, HAO Boxing2. |
1.Department of Obstetrics and Gynecology, Laishui County Hospital, Laishui 074100, China; 2.Department of Obstetrics and Gynecology, Zhuozhou City Hospital,Zhuozhou 072750, China |
|
|
Abstract Objective To evaluate the clinical efficacy of carboprost methylate suppository combined with Bakri uterine tamponade balloon catheter in postpartum hemorrhage.Methods One hundred cases of postpartum hemorrhage who had signed informed consent were randomly divided into the observation group and control group, with 50 cases in each. Patients in the control group were given intra-uterine pack with sterilized gauze to stanch blood while the observation group was treated with carboprost methylate suppository 1 mg sublingual combined with Bakri uterine tamponade balloon catheter to stop bleeding. The patients’ vital signs, adverse reactions and prognosis were monitored. The amount of bleeding, diastolic blood pressure, systolic blood pressure, pulse and hemoglobin were measured before treatment and 2 h, 24 h after treatment.Results The prognostic indexes, such as the effective hemostatic rate and blood transfusion rate, of the observation group were significantly better than those of the control group(P<0.05). The amount of bleeding in the two groups was significantly lower after treatment(P<0.05). The systolic blood pressure of the observation group was better than that before treatment, and the difference was statistically significant(P<0.05). There was no significant difference between the two groups in the diastolic blood pressure, systolic blood pressure, pulse, hemoglobin or adverse reactions.Conclusions The clinical effect of carboprost methylate suppository combined with Bakri uterine tamponade balloon catheter in postpartum hemorrhage is definite and the prognosis is better. This treatment is worthy of clinical application.
|
Received: 11 December 2017
|
|
|
|
|
[1] |
呼改琴,黑江荣.产后出血4280例相关因素分析[J].陕西医学杂志,2014,43(7):802-803.
|
[2] |
韩秀琴,李荣英,孙亚丽.卡贝缩宫素预防宫缩乏力性产后出血疗效观察[J].武警医学,2016,27(5):479-481.
|
[3] |
漆洪波,贾小燕.如何准确评估出血量及产后出血的早期识别[J].中国实用妇科与产科杂志,2014,30(4):254-256.
|
[4] |
Matsubara S,Yano H,Ohkuchi A,et al. Uterine compression sutures for postpartum hemorrhage: an overview [J]. Acta Obstet Gynecol Scand,2013,92(4):378-385.
|
[5] |
Cekmez Y, Ozkaya E, Ocal F D, et al. Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon[J]. Ir J Med Sci, 2015,184(2): 399-402.
|
[6] |
蒋小芒.宫腔内放置球囊压迫在治疗产后出血中的应用[J].陕西医学杂志,2015,44(10):1305-1306.
|
[7] |
Dahlke J,Mendez-Figueroa H,Maggio L,et al. Prevention and management of postpartum hemorrhage:a comparison of 4 national guidelines[J].Am J Obstet Gynecol,2015,213(1):76-80.
|
[8] |
董开杰,曲晓燕.卡前列甲酯栓联合Bakri球囊治疗产后出血的疗效观察[J].现代药物与临床,2016,31(6):893-896.
|
[9] |
陈寒波.卡前列甲酯栓对产妇产后出血的预防效果及安全性评价[J].实用药物与临床,2014,17(2):240-242.
|
[10] |
何 川,尹智华,杨 孜,等.卡前列甲酯防治产后出血系统评价[J].中国实用妇科与产科杂志,2013,29(6):486-492.
|
[11] |
江晓丽,邹橞怡,岑晓燕.浅谈卡前列甲酯栓在预防产后出血中的效果[J].中国现代药物应用,2016,10(11):220-221.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(7): 725-724. |
|
|
|
|